A5102775784- Cutaneous lymphoproliferative disorders research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Autoimmune Bullous Skin Diseases
- Mast cells and histamine
- Nail Diseases and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Facial Rejuvenation and Surgery Techniques
- Neuroendocrine Tumor Research Advances
- Viral Infectious Diseases and Gene Expression in Insects
- Cancer and Skin Lesions
- Antenna Design and Analysis
- Full-Duplex Wireless Communications
- T-cell and Retrovirus Studies
- Cancer Genomics and Diagnostics
- Cutaneous Melanoma Detection and Management
- Polyomavirus and related diseases
- Parathyroid Disorders and Treatments
- Immune cells in cancer
- Virus-based gene therapy research
- Body Contouring and Surgery
- Immunotherapy and Immune Responses
- SARS-CoV-2 and COVID-19 Research
- Dermatologic Treatments and Research
- Lymphoma Diagnosis and Treatment
The University of Texas MD Anderson Cancer Center
2023-2024
Baylor College of Medicine
2023-2024
ABSTRACT Background There has been a proliferation of physicians different levels experience and training offering nonsurgical cosmetic procedures. Rising demand, compounded by increasing utilization new existing technologies numerous physician specialties, compels discussion adequate standardized patient safety. Methods A retrospective chart review patients who presented to our single site dermatology clinic for managment complications following chemical peel, laser or energy‐based device...
<h3>Background</h3> We previously found that personalized mRNA vaccines enhance responses to immune checkpoint inhibition (ICI) by stimulating IFN-α-dependent increases in PD-L1 expression tumors. hypothesized encoding non-tumor antigens, including those targeting SARS-COV-2, would similarly augment ICI secretion of IFN-α and expression. <h3>Methods</h3> analyzed plasma from a cohort healthy volunteers (n=5) at baseline 6 hours, 24 1 week, 2 weeks after SARS-COV-2 vaccination with...
Abstract Although immune checkpoint inhibitor (ICI) effectiveness is correlated with intra-tumoral PD-L1 expression, there are no clinically available methods to improve sensitivity ICIs by modulating expression. mRNA vaccines stimulate robust interferon-dependent innate activation leading four-fold increases in expression on peripheral and intratumoral myeloid cells enhanced blockade preclinical models (Sayour, Grippin, et al., NanoLetters, 2018; Mendez-Gomez, Cell, 2024). We hypothesized...